TWIN LABORATORI
Drug class
Vitamin D
The vitamin D therapeutic drug class comprises fat-soluble secosteroid compounds and analogs, most notably ergocalciferol and cholecalciferol, that function as essential hormonal precursors in mineral homeostasis. Read more about Vitamin D
307 drugs in this class 101 manufacturers
Drugs in Vitamin D
HEARTBURN & ACID REFLUX (calcium citrate,phosphate/vitamin D3/vit B6/folic ac/vit B12)
CALCIUM · VITAMIN DEFICIENCY ·+3
MASON DISTRIB.
KIDS COD LIVER OIL +D (vitamin A/ascorbic acid/cholecalciferol (vit D3)/cod liver)
VITAMIN A · VITAMIN DEFICIENCY ·+1
MASON DISTRIB.
CALCIUM 500 + VITAMIN D (calcium carbonate/cholecalciferol (vitamin D3))
CALCIUM · VITAMIN D DEFICIENCY ·+5
Walgreen Co
KIDS VITAMIN D3 (cholecalciferol (vitamin D3))
VITAMIN D · HYPOPARATHYROIDISM ·+6
MASON DISTRIB.
CALCIUM-FOLIC ACID PLUS D (calcium carb/mag oxide/vitamin D3/vit B12/FA/vit B6/boron)
CALCIUM · VITAMIN DEFICIENCY ·+3
ACELLA PHARMACE
Walgreen Co
D-VI-SOL (cholecalciferol (vitamin D3))
VITAMIN D · HYPOPARATHYROIDISM ·+6
MJ NUTRITIONAL
Bayer HealthCare
Filter & compare in the drug finder →
Opens the drug finder with Vitamin D preselected. Add indication or manufacturer filters there.
The vitamin D therapeutic drug class comprises fat-soluble secosteroid compounds and analogs, most notably ergocalciferol and cholecalciferol, that function as essential hormonal precursors in mineral homeostasis.
Agents in this class undergo sequential hepatic and renal hydroxylation into biologically active forms that bind intracellular vitamin D receptors, enhancing intestinal absorption and renal reabsorption of calcium and phosphate while regulating bone remodeling.
Clinically, these agents are primarily indicated for the prevention and treatment of nutritional rickets, osteomalacia, osteoporosis, hypocalcemia associated with hypoparathyroidism, and metabolic bone disease secondary to chronic kidney disease.
-
fda.gov
The vitamin D therapeutic drug class comprises fat-soluble secosteroid compounds and analogs, most notably ergocalciferol and cholecalciferol, that function as essential hormonal precursors in mineral homeostasis
-
fda.gov
The vitamin D therapeutic drug class comprises fat-soluble secosteroid compounds and analogs, most notably ergocalciferol and cholecalciferol, that function as essential hormonal precursors in mineral homeostasis Agents in this class undergo sequential hepatic and renal hydroxylation into biologically active forms that bind intracellular vitamin D receptors, enhancing intestinal absorption and renal reabsorption of calcium and phosphate while regulating bone remodeling Clinically, these agents a...
-
cancer.gov
The vitamin D therapeutic drug class comprises fat-soluble secosteroid compounds and analogs, most notably ergocalciferol and cholecalciferol, that function as essential hormonal precursors in mineral homeostasis
-
nih.gov
Agents in this class undergo sequential hepatic and renal hydroxylation into biologically active forms that bind intracellular vitamin D receptors, enhancing intestinal absorption and renal reabsorption of calcium and phosphate while regulating bone remodeling Clinically, these agents are primarily indicated for the prevention and treatment of nutritional rickets, osteomalacia, osteoporosis, hypocalcemia associated with hypoparathyroidism, and metabolic bone disease secondary to chronic kidney d...
-
nih.gov
Agents in this class undergo sequential hepatic and renal hydroxylation into biologically active forms that bind intracellular vitamin D receptors, enhancing intestinal absorption and renal reabsorption of calcium and phosphate while regulating bone remodeling
-
fda.gov
Clinically, these agents are primarily indicated for the prevention and treatment of nutritional rickets, osteomalacia, osteoporosis, hypocalcemia associated with hypoparathyroidism, and metabolic bone disease secondary to chronic kidney disease
-
fda.gov
Clinically, these agents are primarily indicated for the prevention and treatment of nutritional rickets, osteomalacia, osteoporosis, hypocalcemia associated with hypoparathyroidism, and metabolic bone disease secondary to chronic kidney disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.